| A single-cell survey of the small intestinal epithelium AL Haber, M Biton, N Rogel, RH Herbst, K Shekhar, C Smillie, G Burgin, ... Nature 551 (7680), 333-339, 2017 | 1374 | 2017 |
| Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA S Schwartz, DA Bernstein, MR Mumbach, M Jovanovic, RH Herbst, ... Cell 159 (1), 148-162, 2014 | 905 | 2014 |
| Intra-and inter-cellular rewiring of the human colon during ulcerative colitis CS Smillie, M Biton, J Ordovas-Montanes, KM Sullivan, G Burgin, ... Cell 178 (3), 714-730. e22, 2019 | 888 | 2019 |
| A genome-wide CRISPR screen in primary immune cells to dissect regulatory networks O Parnas, M Jovanovic, TM Eisenhaure, RH Herbst, A Dixit, CJ Ye, ... Cell 162 (3), 675-686, 2015 | 502 | 2015 |
| T helper cell cytokines modulate intestinal stem cell renewal and differentiation M Biton, AL Haber, N Rogel, G Burgin, S Beyaz, A Schnell, O Ashenberg, ... Cell 175 (5), 1307-1320. e22, 2018 | 454 | 2018 |
| Chromosomal duplication is a transient evolutionary solution to stress AH Yona, YS Manor, RH Herbst, GH Romano, A Mitchell, M Kupiec, ... Proceedings of the National Academy of Sciences 109 (51), 21010-21015, 2012 | 399 | 2012 |
| A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells M Singer, C Wang, L Cong, ND Marjanovic, MS Kowalczyk, H Zhang, ... Cell 166 (6), 1500-1511. e9, 2016 | 398 | 2016 |
| A cellular and spatial map of the choroid plexus across brain ventricles and ages N Dani, RH Herbst, C McCabe, GS Green, K Kaiser, JP Head, J Cui, ... Cell 184 (11), 3056-3074. e21, 2021 | 191 | 2021 |
| Calcitonin gene-related peptide negatively regulates alarmin-driven type 2 innate lymphoid cell responses A Wallrapp, PR Burkett, SJ Riesenfeld, SJ Kim, E Christian, ... Immunity 51 (4), 709-723. e6, 2019 | 153 | 2019 |
| Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes JM Schenkel, RH Herbst, D Canner, A Li, M Hillman, SL Shanahan, ... Immunity 54 (10), 2338-2353. e6, 2021 | 132 | 2021 |
| IL-33 signaling alters regulatory T cell diversity in support of tumor development A Li, RH Herbst, D Canner, JM Schenkel, OC Smith, JY Kim, M Hillman, ... Cell reports 29 (10), 2998-3008. e8, 2019 | 66 | 2019 |
| Heterosis as a consequence of regulatory incompatibility RH Herbst, D Bar-Zvi, S Reikhav, I Soifer, M Breker, G Jona, E Shimoni, ... BMC biology 15, 1-15, 2017 | 43 | 2017 |
| A genomic integration method for the simultaneous visualization of endogenous mRNAs and their translation products in living yeast L Haim-Vilmovsky, N Gadir, RH Herbst, JE Gerst Rna 17 (12), 2249-2255, 2011 | 29 | 2011 |
| 658MO Cisplatin (cis)-related immunomodulation and efficacy with atezolizumab (atezo)+ cis-vs carboplatin (carbo)-based chemotherapy (chemo) in metastatic urothelial cancer (mUC) MD Galsky, X Guan, R Banchereau, L Wang, J Zhu, H Yu, D Rishipathak, ... Annals of Oncology 32, S682-S683, 2021 | 15 | 2021 |
| Rewiring of the cellular and inter-cellular landscape of the human colon during ulcerative colitis CS Smillie, M Biton, J Ordovas-Montanes, KM Sullivan, G Burgin, ... BioRxiv, 2019 | 5 | 2019 |
| Longitudinal single cell profiling of regulatory T cells identifies IL-33 as a driver of tumor immunosuppression A Li, RH Herbst, D Canner, JM Schenkel, OC Smith, JY Kim, M Hillman, ... bioRxiv, 512905, 2019 | 3 | 2019 |
| T helper cells modulate intestinal stem cell renewal and differentiation M Biton, AL Haber, S Beyaz, N Rogel, C Smillie, K Shekhar, A Schnell, ... bioRxiv, 217133, 2017 | 3 | 2017 |
| Immunomodulatory effects and improved outcomes with cisplatin-versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer MD Galsky, X Guan, D Rishipathak, AS Rapaport, HM Shehata, ... Cell Reports Medicine 5 (2), 2024 | 2 | 2024 |
| Modulation of intestinal epithelial cell differentiation, maintenance and/or function through t cell action A Haber, M Biton, N ROGEL, RH HERBST, K SHEKHAR, C SMILLIE, ... | 2 | 2018 |
| Methods and compositions for overcoming immunosuppression A Li, RH Herbst, A Regev, T Jacks, D Canner US Patent 11,739,156, 2023 | 1 | 2023 |
